Status:

COMPLETED

Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line

Lead Sponsor:

Vantive Health LLC

Collaborating Sponsors:

Gambro Lundia AB

Baxter Healthcare Corporation

Conditions:

Chronic Kidney Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary objective is to collect data to evaluate the biocompatibility of two types of blood circuit, already on the market.

Detailed Description

Interactions between blood components (cells and proteins) and the extracorporeal circuit induce the activation of several biological systems such as platelets, complement and coagulation cascades. Th...

Eligibility Criteria

Inclusion

  • Patients suffering from chronic renal failure,
  • Patients treated in HD performed with or without heparin injection in the extra corporeal circuit (ECC) irrespective the type of heparin (UFH and LMWH),
  • Patients treated three times a week for a minimum of three (3) months,
  • Patients 18 years or older,
  • Patients with a well-functioning vascular access as judged by the investigator,
  • Patients with negative serologies (HIV, hepatitis),
  • Patients having signed written informed consent to participate in the study.

Exclusion

  • Patients with known allergy to heparin,
  • Patients with acute inflammatory event that may affect, as judged by the investigator, the results of the study or the safety of the patients,
  • Active malignant disease,
  • Pregnant women, nursing mothers and women planning a pregnancy during the course of the study,
  • Patients under guardianship,
  • Patients participating in other studies that could interfere with the objectives of this study,
  • Patients treated in single needle mode,
  • Patients with catheter,
  • Patients receiving Anti-Vit K drug.

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT00804453

Start Date

November 1 2008

End Date

November 1 2008

Last Update

March 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AURAL

Bourgoin, France, 38 317